{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:13:12Z","timestamp":1795029192439,"version":"4.10.2"},"reference-count":74,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Romanian Ministry of Research and Innovation, CNCS\u2013UEFISCDI","award":["PN-III-P4-ID-PCCF-2016\u20130050"],"award-info":[{"award-number":["PN-III-P4-ID-PCCF-2016\u20130050"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the essential reaction of CO2 hydration in all living organisms, being actively involved in the regulation of a plethora of patho-\/physiological conditions. A series of chromene-based sulfonamides were synthesized and tested as possible CA inhibitors. On the other hand, in microorganisms, the \u03b2- and \u03b3- classes are expressed in addition to the \u03b1- class, showing substantial structural differences to the human isoforms. In this scenario, not only human but also bacterial CAs are of particular interest as new antibacterial agents with an alternative mechanism of action for fighting the emerging problem of extensive drug resistance afflicting most countries worldwide. Pyrazolo[4,3-c]pyridine sulfonamides were synthesized using methods of organic chemistry. Their inhibitory activity, assessed against the cytosolic human isoforms hCA I and hCA II, the transmembrane hCA IX and XII, and \u03b2- and \u03b3-CAs from three different bacterial strains, was evaluated by a stopped-flow CO2 hydrase assay. Several of the investigated derivatives showed interesting inhibition activity towards the cytosolic associate isoforms hCA I and hCA II, as well as the 3\u03b2- and 3\u03b3-CAs. Furthermore, computational procedures were used to investigate the binding mode of this class of compounds within the active site of hCA IX. Four compounds (1f, 1g, 1h and 1k) were more potent than AAZ against hCA I. Furthermore, compound 1f also showed better activity than AAZ against the hCA II isoform. Moreover, ten compounds out of eleven appeared to be very potent against the \u03b3-CA from E.coli, with a Ki much lower than that of the reference drug. Most of the compounds showed better activity than AAZ against hCA I as well as the \u03b3-CA from E.coli and the \u03b2-CA from Burkholderia pseudomallei (BpsCA\u03b2). Compounds 1f and 1k showed a good selectivity index against hCA I and hCA XII, while 1b was selective against all 3\u03b2-CA isoforms from E.coli, BpsCA, and VhCA and all 3\u03b3-CA isoforms from E.coli, BpsCA and PgiCA.<\/jats:p>","DOI":"10.3390\/ph15030316","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T01:53:54Z","timestamp":1646790834000},"page":"316","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pyrazolo[4,3-c]pyridine Sulfonamides as Carbonic Anhydrase Inhibitors: Synthesis, Biological and In Silico Studies"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7192","authenticated-orcid":false,"given":"Andrea","family":"Angeli","sequence":"first","affiliation":[{"name":"Sezione di Scienze Farmaceutiche, NeuroFarba Department, Universita degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy"},{"name":"Centre of Advanced Research in Bionanoconjugates and Biopolymers, Petru Poni Institute of Macromolecular Chemistry, Aleea Grigore Ghica-Voda, no. 41A, 700487 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Kartsev","sequence":"additional","affiliation":[{"name":"InterBioScreen, 142432 Chernogolovka, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8587-2710","authenticated-orcid":false,"given":"Anthi","family":"Petrou","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-4519","authenticated-orcid":false,"given":"Boris","family":"Lichitsky","sequence":"additional","affiliation":[{"name":"Zelinsky Institute of Organic Chemistry, Leninsky Prospect, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7364-3478","authenticated-orcid":false,"given":"Andrey","family":"Komogortsev","sequence":"additional","affiliation":[{"name":"Zelinsky Institute of Organic Chemistry, Leninsky Prospect, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4021-982X","authenticated-orcid":false,"given":"Mariana","family":"Pinteala","sequence":"additional","affiliation":[{"name":"Centre of Advanced Research in Bionanoconjugates and Biopolymers, Petru Poni Institute of Macromolecular Chemistry, Aleea Grigore Ghica-Voda, no. 41A, 700487 Iasi, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-7777","authenticated-orcid":false,"given":"Athina","family":"Geronikaki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[{"name":"Sezione di Scienze Farmaceutiche, NeuroFarba Department, Universita degli Studi di Firenze, Via Ugo Schiff 6, 50019 Sesto Fiorentino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Supuran, C.T., and Capasso, C. (2017). An Overview of the Bacterial Carbonic Anhydrases. Metabolites, 7.","DOI":"10.3390\/metabo7040056"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543776.2020.1811853","article-title":"Antibacterial carbonic anhydrase inhibitors: An update on the recent literature","volume":"30","author":"Supuran","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: Novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1042\/CS20210040","article-title":"Emerging role of carbonic anhydrase inhibitors","volume":"135","author":"Supuran","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J. Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1016\/j.ejmech.2010.10.005","article-title":"Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors","volume":"45","author":"Fioravanti","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jhet.3045","article-title":"4-Formyl-Pyrazole-3-Carboxylate: A Useful Aldo-X Bifunctional Precursor for the Syntheses of Pyrazole-fused\/Substituted Frameworks","volume":"55","author":"Devi","year":"2018","journal-title":"J. Heterocycl. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0091-3057(84)80027-1","article-title":"Effects of zometapine, A structurally novel antidepressant, in an animal model of depression","volume":"21","author":"Katz","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_10","first-page":"121","article-title":"Lorediplon: A New GABAA Modulator Drug for Treatment of Insomnia","volume":"49","author":"Santos","year":"2015","journal-title":"Drug Treat. Sleep Disord."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/en.2012-1855","article-title":"Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice","volume":"154","author":"Ervinna","year":"2013","journal-title":"Endocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Marinescu, M. (2021). Synthesis of Antimicrobial Benzimidazole\u2013Pyrazole Compounds and Their Biological Activities. Antibiotics, 10.","DOI":"10.3390\/antibiotics10081002"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jscs.2016.05.008","article-title":"A study on synthesis and antimicrobial activity of 4-acyl-pyrazoles","volume":"22","author":"Cetin","year":"2018","journal-title":"J. Saudi Chem. Soc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.2174\/1389557519666190313095545","article-title":"Synthesis of Novel Bis-pyrazole Derivatives as Antimicrobial Agents","volume":"19","author":"Muhammad","year":"2019","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1021\/acs.jmedchem.8b00931","article-title":"Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication","volume":"61","author":"Scheers","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"ftx078","DOI":"10.1093\/femspd\/ftx078","article-title":"Design, synthesis and antiviral evaluation of novel heteroarylcarbothioamide derivatives as dual inhibitors of HIV-1 reverse transcriptase-associated RNase H and RDDP functions","volume":"75","author":"Corona","year":"2017","journal-title":"Pathog. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101767","DOI":"10.1016\/j.jksus.2021.101767","article-title":"Pyrazolo[3,4-b]pyridin-3(2H)-one derivatives: Synthesis and their investigation of mosquito larvicidal activity","volume":"34","author":"Rudayni","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bioorg.2017.11.010","article-title":"Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents","volume":"76","author":"Naim","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/14756366.2016.1180594","article-title":"Synthesis and biological evaluation of fluoropyrazolesulfonylurea and thiourea derivatives as possible antidiabetic agents","volume":"31","author":"Faidallah","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Li, X., Yu, Y., and Tu, Z. (2021). Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer\u2019s Disease and Parkinson\u2019s Disease Treatment (2011\u20132020). Molecules, 26.","DOI":"10.3390\/molecules26051202"},{"key":"ref_21","first-page":"47","article-title":"Synthesis, Docking and Evaluation of Novel Pyrazole Carboxamide Derivatives as Multifunctional Anti-Alzheimer\u2019s Agents","volume":"2","author":"Lather","year":"2017","journal-title":"J. Med. Chem. Toxicol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1573406414666180524084023","article-title":"Pyrazole and imidazo[1,2-b]pyrazole Derivatives as New Potential Antituberculosis Agents","volume":"15","author":"Meta","year":"2019","journal-title":"Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2017.07.059","article-title":"Recent advances of pyrazole-containing derivatives as anti-tubercular agents","volume":"139","author":"Xu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4155\/fmc-2018-0058","article-title":"Synthesis, molecular modeling and biological screening of some pyrazole derivatives as antileishmanial agents","volume":"10","author":"Bekhit","year":"2018","journal-title":"Future Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bioorg.2018.02.002","article-title":"Evaluation of \u03b1-glucosidase inhibiting potentials with docking calculations of synthesized arylidene-pyrazolones","volume":"77","author":"Chaudhry","year":"2018","journal-title":"Bioorg. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejmech.2018.04.025","article-title":"New pyrazolopyridine analogs: Synthesis, antimicrobial, antiquorum-sensing and antitumor screening","volume":"152","author":"Shaaban","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1248\/bpb.b15-00586","article-title":"Novel Pyrazolo[3,4-b]pyridine Derivatives: Synthesis, Characterization, Antimicrobial and Antiproliferative Profile","volume":"39","author":"Salem","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejmech.2013.04.043","article-title":"Microwave-assisted synthesis of some new pyrazolopyridines and their antioxidant, antitumor and antimicrobial activities","volume":"66","author":"Rizk","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1021\/jm00132a011","article-title":"Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents","volume":"32","author":"Bare","year":"1989","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gu, X., and Ma, S. (Anti Cancer Agents Med. Chem., 2021). Recent Advances in the Development of Pyrazolopyridines as Anticancer Agents, Anti Cancer Agents Med. Chem.","DOI":"10.2174\/1871520621666210901102832"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1389557521666210325115218","article-title":"Recent Progress in Anticancer Agents Incorporating Pyrazole Scaffold","volume":"22","author":"Mor","year":"2022","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1573406412666161213124450","article-title":"Synthesis and antiproliferative activity of new pyrazolo[3,4-c]pyridines","volume":"13","author":"Gavriil","year":"2017","journal-title":"Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1016\/j.bmcl.2016.09.056","article-title":"The discovery of new cytotoxic pyrazolopyridine derivatives","volume":"26","author":"Giannouli","year":"2016","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/acs.jmedchem.6b01447","article-title":"Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine","volume":"60","author":"Anand","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1021\/jm0401006","article-title":"Antileishmanial Pyrazolopyridine Derivatives: Synthesis and Structure\u2212Activity Relationship Analysis","volume":"47","author":"Echevarria","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Pinheiro, L.C.S., Feitosa, L.M., Gandi, M.O., Silveira, F.F., and Boechat, N. (2019). The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines. Molecules, 24.","DOI":"10.3390\/molecules24224095"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.bmcl.2008.05.052","article-title":"Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors","volume":"18","author":"Hamblin","year":"2008","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1248\/cpb.c16-00704","article-title":"Synthesis, Docking Study and Kinase Inhibitory Activity of a Number of New Substituted Pyrazolo[3,4-c]pyridines","volume":"65","author":"Sklepari","year":"2017","journal-title":"Chem. Pharm. Bull."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmech.2016.05.035","article-title":"Novel pyrazolopyridine derivatives as potential angiogenesis inhibitors: Synthesis, biological evaluation and transcriptome-based mechanistic analysis","volume":"121","author":"Michailidou","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_40","first-page":"849","article-title":"Synthesis and biological evaluation of sulfonamide derivatives as antimicrobial agents","volume":"74","author":"Abbas","year":"2017","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"42983","DOI":"10.1039\/D0RA09051D","article-title":"Folic acid-sulfonamide conjugates as antibacterial agents: Design, synthesis and molecular docking studies","volume":"10","author":"Shahzad","year":"2020","journal-title":"RSC Adv."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4236\/ijoc.2021.114014","article-title":"Design, Synthesis and Characterization of Novel Sulfonamides Derivatives as Anticancer Agent Targeting EGFR TK, and Development of New Methods of Synthesis by Microwave Irradiation","volume":"11","author":"Akili","year":"2021","journal-title":"Int. J. Org. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"31854","DOI":"10.1021\/acsomega.1c04552","article-title":"Investigations on Anticancer and Antimalarial Activities of Indole-Sulfonamide Derivatives and In Silico Studies","volume":"6","author":"Pingaew","year":"2021","journal-title":"ACS Omega"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Alshibl, H.M., Al-Abdullah, E.S., Haiba, M.E., Alkahtani, H.M., Awad, G.E., Mahmoud, A.H., Ibrahim, B.M., Bari, A., and Villinger, A. (2020). Synthesis and Evaluation of New Coumarin Derivatives as Antioxidant, Antimicrobial, and Anti-Inflammatory Agents. Molecules, 25.","DOI":"10.3390\/molecules25143251"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1021\/acs.jmedchem.8b00420","article-title":"Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs\u2013CAIs) for the Management of Rheumatoid Arthritis","volume":"61","author":"Akgul","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.5530\/ijper.55.4.214","article-title":"Synthesis, Characterization and Antidiabetic Evaluation of Sulfonamide in Corporated with 1,3,4-Oxadiazole Derivatives","volume":"55","author":"Salve","year":"2021","journal-title":"IJPER"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10401","DOI":"10.1021\/acsomega.0c00280","article-title":"Design, Synthesis, and Antimicrobial Evaluation of a New Series of N-Sulfonamide 2-Pyridones as Dual Inhibitors of DHPS and DHFR Enzymes","volume":"5","author":"Azzam","year":"2020","journal-title":"ACS Omega"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/14756366.2016.1198900","article-title":"A class of sulfonamides as carbonic anhydrase I and II inhibitors","volume":"31","author":"Gokcen","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Giovannuzzi, S., D\u2019Ambrosio, M., Luceri, S., Osman, S.M., Pallecchi, M., Bartolucci, G., Nocentini, A., and Supuran, C.T. (2022). Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010461"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","article-title":"Sulfonamide Inhibitors of Human Carbonic Anhydrases Designed through a Three-Tails Approach: Improving Ligand\/Isoform Matching and Selectivity of Action","volume":"63","author":"Bonardi","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Angeli, A., Kartsev, V., Petrou, A., Pinteala, M., Brovarets, V., Vydzhak, R., Panchishin, S., Geronikaki, A., and Supuran, C.T. (2021). Carbonic Anhydrase Inhibition with Sulfonamides Incorporating Pyrazole- and Pyridazinecarboxamide Moieties Provides Examples of Isoform-Selective Inhibitors. Molecules, 26.","DOI":"10.3390\/molecules26227023"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Angeli, A., Kartsev, V., Petrou, A., Pinteala, M., Vydzhak, R.M., Panchishin, S.Y., Brovarets, V., De Luca, V., Capasso, C., and Geronikaki, A. (2021). New Sulfanilamide Derivatives Incorporating Heterocyclic Carboxamide Moieties as Carbonic Anhydrase Inhibitors. Pharmaceuticals, 14.","DOI":"10.3390\/ph14080828"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Angeli, A., Kartsev, V., Petrou, A., Pinteala, M., Brovarets, V., Slyvchuk, S., Pilyo, S., Geronikaki, A., and Supuran, C. (2021). Chromene-Containing Aromatic Sulfonamides with Carbonic Anhydrase Inhibitory Properties. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105082"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3987\/COM-06-10921","article-title":"Synthesis of 2-unsubstituted 2,3,5,6,7,8-Hexahydropyrazolo[4,3-d][1,2]diazepinone-8-carboxylates","volume":"71","author":"Bevk","year":"2007","journal-title":"Heterocycles"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jhet.5570310508","article-title":"Acylaminoacetyl derivatives of active methylene compounds. 3.C-Acylation Reactionsviathe Hippuric Acid Azlactone","volume":"31","author":"Hamilakis","year":"1994","journal-title":"J. Heterocycl. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1002\/chem.202002581","article-title":"Photochemical Approach to the Cyclohepta[b]indole Scaffold by Annulative Two-Carbon Ring-Expansion","volume":"26","author":"Hiersemann","year":"2020","journal-title":"Chem. A Eur. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.tetlet.2016.02.043","article-title":"Triacetic acid lactone as a common intermediate for the synthesis of 4-hydroxy-2-pyridones and 4-amino-2-pyrones","volume":"57","author":"Kraus","year":"2016","journal-title":"Tetrahedron Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/jhet.5570300458","article-title":"Reaction of amines on 3-ureidomethylenecoumarins. A new route to N-(methylene-4-oxocoumarinyl)amines","volume":"30","author":"Hamdi","year":"1993","journal-title":"J. Heterocycl. Chem."},{"key":"ref_59","first-page":"3001","article-title":"The Formation of Polyheterocyclic Systems by the Reaction of 2-Oxo-2H- 1-benzopyran-3-carboxamide and Related Compounds with Active Methylene Compounds","volume":"12","author":"Mcmurry","year":"1995","journal-title":"J. Chem. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1016\/j.bmcl.2010.07.051","article-title":"Crystal structure of the C183S\/C217S mutant of human CA VII in complex with acetazolamide","volume":"20","author":"Truppo","year":"2010","journal-title":"Bioorgan. Med. Chem. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2174\/1568026616666160413135522","article-title":"An Overview of the Carbonic Anhydrases from Two Pathogens of the Oral Cavity: Streptococcus mutans and Porphyromonas gingivalis","volume":"16","author":"Capasso","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/14756366.2013.787422","article-title":"Sulfa and trimethoprim-like drugs-antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors","volume":"29","author":"Capasso","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1016\/j.bmc.2015.05.029","article-title":"Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa","volume":"23","author":"Pinard","year":"2015","journal-title":"Bioorgan. Med. Chem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.bmcl.2013.01.084","article-title":"Anion inhibition studies of the \u03b1-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae","volume":"23","author":"Vullo","year":"2013","journal-title":"Bioorgan. Med. Chem. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9222","DOI":"10.1021\/bi000204s","article-title":"A closer look at the active site of gamma-class carbonic anhydrases: High-resolution crystallographic studies of the carbonic anhydrase from Methanosarcina thermophila","volume":"39","author":"Iverson","year":"2000","journal-title":"Biochemistry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: The rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_71","unstructured":"(2020, May 30). A Structural View of Biology. Available online: http:\/\/www.rcsb.org\/."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/14756366.2018.1468530","article-title":"Activation of \u03b2- and \u03b3-carbonic anhydrases from pathogenic bacteria with tripeptides","volume":"33","author":"Stefanucci","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejmech.2018.05.026","article-title":"Design, synthesis and X-ray crystallography of selenides bearing benzenesulfonamide moiety with neuropathic pain modulating effects","volume":"154","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Angeli, A., Pinteala, M., Maier, S.S., Simionescu, B.C., Milaneschi, A., Abbas, G., Del Prete, S., Capasso, C., Capperucci, A., and Tanini, D. (2020). Evaluation of Thio- and Seleno-Acetamides Bearing Benzenesulfonamide as Inhibitor of Carbonic Anhydrases from Different Pathogenic Bacteria. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020598"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/3\/316\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:33:10Z","timestamp":1760135590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/3\/316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":74,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ph15030316"],"URL":"https:\/\/doi.org\/10.3390\/ph15030316","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]}}}